Vimarsana
Biggest News Aggregation in the World

Page 27 - Neurological Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neurological Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neurological Sciences Today - Breaking & Trending Today

NIMHANS files complaint over a month after ransomware attack: Report - Vimarsana News

NIMHANS files complaint over a month after ransomware attack: Report

The administration of Bengaluru's National Institute of Mental Health and Neurological Sciences (NIMHANS) filed a police complaint against a ransomware attack it suffered from on March 23 only a month later on April 30.

Study finds 67% of individuals with long COVID are developing dysautonomia - Vimarsana News

Study finds 67% of individuals with long COVID are developing dysautonomia

In a recent study posted to the medRxiv* preprint server, researchers analyzed the traits of autonomic symptom burden in long coronavirus disease (COVID).

Horizon Therapeutics plc Receives European Commission (EC) Approval of UPLIZNA (inebilizumab) for the Treatment of Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD) - Vimarsana News

Horizon Therapeutics plc Receives European Commission (EC) Approval of UPLIZNA (inebilizumab) for the Treatment of Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)

-- NMOSD is a devastating autoimmune disease of severe and recurrent central nervous system attacks which can result in blindness, paralysis and death -- -- UPLIZNA is indicated as monotherapy for

Horizon Therapeutics plc Receives European Commission (EC) Approval of UPLIZNA® (inebilizumab) for the Treatment of Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD) - Vimarsana News

Horizon Therapeutics plc Receives European Commission (EC) Approval of UPLIZNA® (inebilizumab) for the Treatment of Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Horizon Therapeutics plc Receives European Commission (EC) Approval of UPLIZNA® (inebilizumab) for the Treatment of Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD) - read this article along with other careers information, tips and advice on BioSpace

An Estimated 38 Million Americans Have Developed an Autonomic Nervous System Disorder Following COVID-19 Infection - Vimarsana News

An Estimated 38 Million Americans Have Developed an Autonomic Nervous System Disorder Following COVID-19 Infection

New research from Stanford University and Stony Brook University identifies moderate to severe dysautonomia in 67% of Long COVID patients.